Advisor: Bing Li, PhD

Publications

Hao J, Jin R, Yi Y, Jiang X, Yu J, Xu Z, Schnicker NJ, Chimenti MS, Sugg SL, Li B. Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer. Breast Cancer Research. 2024;26(1). doi:https://doi.org/10.1186/s13058-024-01873-y

Yu J, Jiaqing H, Yorek MS, Han X, Avellino A, Jiang X, Liu S, Wang J, Li B. Determination of the FABP5 expression profile in skin lesions of an IMQ-induced psoriasis mouse model using flow cytometry. STAR Protocols. 2024;5(2):103018-103018. doi:https://doi.org/10.1016/j.xpro.2024.103018

Hao J, Yu J, Yorek MS, Yu CL, Pope RM, Chimenti MS, Xiong Y, Klingelhutz A, Jabbari A, Li B. Keratinocyte FABP5-VCP complex mediates recruitment of neutrophils in psoriasis. Cell Reports. 2023;42(11):113449-113449. doi:https://doi.org/10.1016/j.celrep.2023.113449

Zhu J, Yu J, Hu A, Liu JQ, Pan X, Xin G, Carson WE, Li Z, Yang Y, Bai XF. IL-27 Gene Therapy Induces Stat3-Mediated Expansion of CD11b+Gr1+ Myeloid Cells and Promotes Accumulation of M1 Macrophages in the Tumor Microenvironment. The Journal of Immunology. 2023;211(5):895-902. doi:https://doi.org/10.4049/jimmunol.2300176

Jin R, Hao J, Yu J, Wang P, Sauter ER, Li B. Role of FABP5 in T Cell Lipid Metabolism and Function in the Tumor Microenvironment. Cancers. 2023; 15(3):657. doi:https://doi.org/10.3390/cancers15030657

Hu A, Zhu J, Zeng C, Lin CH, Yu J, Liu JQ, Lynch K, Talebain F, Pan X, Yan J, Dong Y, Li Z, Bai XF. IL-27 Induces CCL5 Production by T Lymphocytes, Which Contributes to Antitumor Activity. The Journal of Immunology. 2022;208(9):2239-2245. doi:https://doi.org/10.4049/jimmunol.2100885

Talebian F, Yu J, Lynch K, Liu JQ, Carson WE, Bai XF. CD200 Blockade Modulates Tumor Immune Microenvironment but Fails to Show Efficacy in Inhibiting Tumor Growth in a Murine Model of Melanoma. Frontiers in Cell and Developmental Biology. 2021;9. doi:https://doi.org/10.3389/fcell.2021.739816

Liu JQ, Zhu J, Hu A, Zhang A, Yang C, Yu J, Ghoshal K, Basu S, Bai XF. Is AAV-delivered IL-27 a potential immunotherapeutic for cancer? Am J Cancer Res. 2020 Nov 1;10(11):3565-3574. PMCID: PMC7716159

Liu JQ, Hu A, Zhu J, Yu J, Talebain F, Bai XF. (2020). CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy. In: Birbrair, A. (eds) Tumor Microenvironment. Advances in Experimental Medicine and Biology, vol 1223. Springer, Cham. doi:https://doi.org/10.1007/978-3-030-35582-1_8